Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Fully adjusted risk ratios are plotted for the end points of hospitalization for chronic obstructive pulmonary disease (COPD), myocardial infarction (MI), death, and MI or death. Treatments analyzed were angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), statins (hydroxymethylglutaryl CoA reductase inhibitors [HMG-CoA]), and the combination of statins with ACE inhibitors or ARBs (combination) in the population of COPD patients without previous MI and newly treated with nonsteroidal anti-inflammatory drugs (low risk). Results including steroid users are in the right panel.
|
